RNS Number : 9575F
NetScientific PLC
26 February 2015
NetScientific plc
(“NetScientific” or the “Group”)
Appointment to the Board
NetScientific appoints Jonathan Paisner as Non-Executive Director
26 February 2015: NetScientific (AIM: NSCI), the biomedical and healthcare technology group is pleased to announce that Jonathan Paisner will join the Board with immediate effect as a non-executive director.
Jonathan is the founder of LMN Capital Limited, a corporate finance advisor which helps management teams access capital from a wide range of investors. He is also a consultant lawyer at law firm Mathias Gentle Page Hassan and has acted as a consultant to NetScientific. Previously, he was on the board of boutique investment bank Shore Capital. He is being appointed by the Azima Family Trusts pursuant to their rights under NetScientific’s Articles of Association to nominate a director.
Commenting on the appointment, Sir Richard Sykes, Executive Chairman of NetScientific, said, “Jonathan’s appointment will further strengthen the Board and the Company’s position in 2015. His expertise and experience, particularly in accessing capital and structuring deals, will be valuable in advancing the Group’s strategy in 2015 and beyond.”
The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies. Jonathan Paisner, aged 45 years, has been a director of the following companies during the five years preceding the date of this announcement:
| Current directorships | Past Directorships |
| LMN Capital Limited | Shore Capital Group plc (now Shore Capital Group Ltd) |
| LMN Capital Partners Limited | Puma Hotels plc |
| Beautyv Limited | Chic Lifestyle Limited |
| The Fabedit Limited | Chic Retreats Limited
British Friends of Hebrew University of Jerusalem Ourpinboard Limited Crowdsyndicator Limited |
-Ends-
Notes to Editors
About NetScientific
NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people’s lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.NetScientific.net
Contact Details
| Liberum (NOMAD and Broker)
Chris Bowman / Christopher Britton |
Tel: +44 (0) 20 3100 2000 |
| Instinctif Partners
Melanie Toyne-Sewell / Tim Watson |
Tel: +44 (0) 20 7457 2020 Email: netscientific@instinctif.com |
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFIIFSIRFIE